Managing director responsible for all fiduciary and business decisions; business strategy, marketing, and business development.
•Lead daily operations of a niche consultancy specializing in the identification and synthesis of RWD to inform business strategy and answer critical patient-centric questions for growing biotech, medical device, and health IT organizations.
•Develop core business offerings and seek opportunities for client partnerships. Design and execute contracted research initiatives as per agreed upon statement of work.
•Foster trust as engaged, scientific, and strategic advisor through attentive and personalized approach with each client.

Led epidemiology team in design and execution of RWD studies on behalf of Life Sciences and Health Systems business partners.
•Provided design-related feedback to engineering and leadership team on proposed new product features.
•Oversaw team interaction with FDA, Friends of Cancer Collaborative (FOCR), and Reagan-Udall Foundation in accelerating the use of RWE in regulatory decision making.
•Collaborated with BD, medical, and commercial leaders to author client business proposals and support remote teleconference meetings.

Collaborated with a series of cross-functional teams to develop and execute global HEOR evidence strategies and tactics
•Coached commercial franchise and therapeutic area partners on U.S. healthcare payment reform measures and projected need for evidence, supporting payer and provider reimbursement and purchase decisions within rapidly evolving marketplace.
•Built team and internal data governance structure and processes to internalize observational EMR and claims based research function, resulting in improved insight and control of data to include capability to generate evidence of greater specificity for demonstration of product value.
•Developed evidence generation plan and process for querying hospital data to trace time to first dose and days continuous use parental nutrition therapy, advancing current understanding of both adult and neonatal population in acute care utilization.
•Piloted novel risk / return forecasting approach for IV therapy in partnership with external con

Worked closely with key client stakeholders across multiple companies to include Deloitte, Giles and Associates, and Northshore University Health-systems to provide leadership and analytical support for several key projects while attending University of Illinois as doctoral graduate student.
•Provided guidance in use of ontologies and health services classification frameworks, improving interpretation of data, translating and summarizing analysis into comprehensive reports.
•Sourced disease incidence and prevalence rates, guiding research and development prioritization of spend, and socializing approach and findings with executives.
•Scoped potential to reduce duplicity of nursing documentation by substituting alternative data fields.

Provided instructional and investigative support to assigned School ofPublic Health professors to augment student learning and advance respective research agenda.
•Worked closely with multiple professors within School of Public Health, contributing to research projects, mentoring students, and adhering to strict research as well as university policies and procedures.

Contributed to conceptualization and development of Hospira MedNet™ Portal, proprietary drug library development and online benchmarking application. Provided knowledge conduit between field-based team and corporate office and represented voice-of-customer needs to internal marketing, therapeutic area, and research and development (R&D) teams.
•Grew professional services consulting team from 4 to 10 FTEs, guiding individual hospitals and integrated delivery networks in implementation and use of IV Safety Software across U.S. and international markets.
•Directed a pharmacy consulting program responsible for generating $2.5-3 million in annual consultant fees, and facilitating collection of $300M in medical device capital revenue,
•Led professional services team in achieving more than 700 successful intelligent infusion installations within U.S. and additional 30 international deployments over 5 years by navigating relationships across large and complex integrated delivery networks.

Managed product life cycle requirements for portfolio of automated dispensing and inventory management cabinets and physician order communication software.
•Presented persuasive proposal, securing $1M in investment for renovation of MedSelect® automated dispensing cabinet line, orchestrating project plan, beta test period, and segmented market launch.
•Led project team in securing funds and external expert resources to define strategy for next generation institutional dispensing platform, delivering next generation proposal on time and within budget.
•Partnered with affiliate team members on key project, reducing 3rd-party expenditures for sister oncology specialty company via development and execution of customized strategy for existing product platform, replacing use of competitor's product line. ADDITIONAL RELEVANT EXPERIENCE

Clinical Pharmacist and Project Manager responsible for various safety studies and management of implementation of various health technologies